The Fashionable Molecule for Healthy Longevity

CBD (cannabidiol) has risen significantly in profile in recent years. Its growing popularity among researchers, patients and casual users alike merits a discussion of its therapeutic promise. This paper provides an overview of clinical applications of CBD that are currently under investigation by the pharmaceutical industry and offers some remarks on the future prospects of CBD-based products.

Let’s Hold the Gains: What are we learning from COVID-19 crisis and how we see these lessons bearing fruit?

In the midst of an unprecedented health emergency, it may seem strange to speak of ‘gains’, i.e. gains from our experience in combatting COVID-19. The loss of loved ones through COVID-19 is a terrible tragedy and no ‘gain’ or advances in our approach can ever outweigh this loss. But in this context, we face an even greater responsibility to be clear on what we are learning from this crisis and how we see these lessons can benefit others in the future post-COVID world.

COVID-19: Planning for the future

Dr Charles Alessi speaks about COVID-19 “exit strategy” based on the use of telemedicine, secondary use of medical data and global hypercollaboration at Public Policy Projects.

Translating the Life Sciences into Human Longevity

Lecture by Prof. Richard Barker at Gowing Life (Oxford, UK)
Barker’s business career has included work in both Europe and the US. He worked for McKinsey between 1980 and 1993, where he headed the European Healthcare practice and advised UK, Swiss and US pharmaceutical companies. He also helped establish ‘London First’, a public/private initiative that aims to enhance London’s status as a global city…

Taking Precision Medicine Global

We have developed a ‘precision medicine readiness index‘, based on the current application of PM thinking and technologies and the level of their integration into the health system(s).